Veritas Pharma (CSE:VRT) announced it has engaged with a branding firm in order to develop a label and package designs in compliance with the regulations from Health Canada for its cannabis products.
As quoted in the press release:
Veritas is applying to amend Cannevert’s Dealer Licence such that the Company can package Cannevert products including CTL-X for sale to licensed producers in Canada and for the export market.
CBD Strategy Group, a cannabis brand and marketing firm, has been retained to help develop brand strategy and guidelines around compliant packaging and labeling for both cannabis import and export.
“We are very excited to work with Dr. Lui Franciosi and the entire Veritas Pharma team. The work that will be done through Cannevert Therapeutics to develop clear, systematic, scientific and batch-to-batch therapeutic cannabis solutions is exciting and exactly where the industry needs to go. As regulation continues to define itself, our goal is to provide Cannevert Therapeutics with brand support and insights on market requirements, which includes compliant label and package development,” said Jenn Larry, President, CBD Strategy Group.